Zenas BioPharma, Inc. (ZBIO)
27.48
-2.16
(-7.27%)
USD |
NASDAQ |
Sep 24, 16:00
27.48
0.00 (0.00%)
After-Hours: 19:59
Zenas BioPharma Price to Book Value : 7.042 for Sept. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 23, 2026 | 7.594 |
| September 22, 2026 | 8.471 |
| September 21, 2026 | 8.342 |
| September 18, 2026 | 8.073 |
| September 17, 2026 | 8.194 |
| September 16, 2026 | 8.284 |
| September 15, 2026 | 8.184 |
| September 14, 2026 | 8.178 |
| September 11, 2026 | 7.976 |
| September 10, 2026 | 7.971 |
| September 09, 2026 | 8.276 |
| September 08, 2026 | 8.471 |
| September 04, 2026 | 8.427 |
| September 03, 2026 | 8.437 |
| September 02, 2026 | 8.491 |
| September 01, 2026 | 8.196 |
| August 31, 2026 | 8.284 |
| August 28, 2026 | 8.014 |
| August 27, 2026 | 8.360 |
| August 26, 2026 | 8.468 |
| August 25, 2026 | 8.655 |
| August 24, 2026 | 8.112 |
| August 21, 2026 | 8.276 |
| August 20, 2026 | 8.104 |
| August 19, 2026 | 8.009 |
| Date | Value |
|---|---|
| August 18, 2026 | 8.178 |
| August 17, 2026 | 7.817 |
| August 14, 2026 | 7.563 |
| August 13, 2026 | 7.484 |
| August 12, 2026 | 8.020 |
| August 11, 2026 | 8.314 |
| August 10, 2026 | 8.199 |
| August 07, 2026 | 8.312 |
| August 06, 2026 | 8.245 |
| August 05, 2026 | 8.166 |
| August 04, 2026 | 8.053 |
| August 03, 2026 | 7.979 |
| July 31, 2026 | 8.058 |
| July 30, 2026 | 8.271 |
| July 29, 2026 | 7.968 |
| July 28, 2026 | 8.276 |
| July 27, 2026 | 8.412 |
| July 24, 2026 | 7.789 |
| July 23, 2026 | 7.943 |
| July 22, 2026 | 8.071 |
| July 21, 2026 | 8.294 |
| July 20, 2026 | 7.868 |
| July 17, 2026 | 7.568 |
| July 16, 2026 | 7.238 |
| July 15, 2026 | 7.538 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.924 |
| Alnylam Pharmaceuticals, Inc. | 24.65 |
| Anika Therapeutics, Inc. | 1.977 |
| Savara, Inc. | 7.256 |
| Vericel Corp. | 5.435 |
Price to Book Value Related Metrics
| PS Ratio | 1424.51 |
| PEG Ratio | -0.0224 |
| Price | 27.48 |
| Earnings Yield | -35.00% |
| Market Cap | 1.740B |
| PEGY Ratio | -0.0224 |